Free Trial

NOVONIX Limited (NASDAQ:NVX) Sees Significant Increase in Short Interest

NOVONIX logo with Computer and Technology background

NOVONIX Limited (NASDAQ:NVX - Get Free Report) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 360,000 shares, a growth of 36.1% from the December 15th total of 264,600 shares. Based on an average trading volume of 162,300 shares, the days-to-cover ratio is currently 2.2 days.

NOVONIX Price Performance

Shares of NASDAQ NVX traded down $0.08 during mid-day trading on Thursday, hitting $1.73. 179,457 shares of the company traded hands, compared to its average volume of 169,664. The company has a current ratio of 6.15, a quick ratio of 5.94 and a debt-to-equity ratio of 0.44. NOVONIX has a 1 year low of $1.40 and a 1 year high of $3.10. The business has a 50 day moving average of $1.89 and a two-hundred day moving average of $1.81.

Institutional Trading of NOVONIX

A hedge fund recently raised its stake in NOVONIX stock. Jane Street Group LLC lifted its position in NOVONIX Limited (NASDAQ:NVX - Free Report) by 103.5% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 34,495 shares of the company's stock after acquiring an additional 17,541 shares during the quarter. Jane Street Group LLC's holdings in NOVONIX were worth $63,000 as of its most recent filing with the SEC. 0.06% of the stock is owned by institutional investors.

NOVONIX Company Profile

(Get Free Report)

NOVONIX Limited provides battery materials and development technology for battery manufacturers, materials companies, automotive original equipment manufacturers (OEMs), and consumer electronics manufacturers in North America, Asia, Australia, and Europe. It operates through Battery Materials and Battery Technology segments.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in NOVONIX Right Now?

Before you consider NOVONIX, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NOVONIX wasn't on the list.

While NOVONIX currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines